PsiOxus Therapeutics

Last updated: August 03, 2025

John Beadle, CEO
John Beadle, CEO
UK | Funding: $192.5M (+)

Website: http://psioxus.com/

PsiOxus aims to be the world’s leading cancer gene therapy company, delivering medicines of value to patients with cancer.